Gene expression profiling of inflamed human endothelial cells and influence of activated protein C

Circulation

Volumn 110, Issue 18, 2004, Pages 2903-2909

  Franscini, Nicola ^a   Bachli, Esther B ^a   Blau, Nenad ^b   Leikauf, Maria Sybille ^a   Schaffner, Andreas ^a   Schoedon, Gabriele ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Cell adhesion molecules; Endothelium; Genes; Inflammation; Interleukins

Indexed keywords

6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE; ACTIVATED PROTEIN C; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C FOS; SERINE PROTEINASE; TETRAHYDROBIOPTERIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL ADHESION; CELL CYCLE; CELL METABOLISM; CELL NUCLEUS; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

BIOPTERIN; BLOOD COAGULATION FACTORS; CELL ADHESION MOLECULES; CELLS, CULTURED; CORONARY VESSELS; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN C; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBIN; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 8144228302     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000146344.49689.BB     Document Type: Article

References (33)

1. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-508.
2. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340:207-214.
3. Hack CE, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med. 2001;29:21-27.
4. Coughlin SR. Sol Sherry lecture in thrombosis: how thrombin "talks"to cells: molecular mechanisms and roles in vivo. Arterioscler Thromb Vasc Biol. 1998;18:514-518.
5. Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003;31:221-230.
6. Esmon CT. Role of coagulation inhibitors in inflammation. Thromb Haemost. 2001;86:51-56.
7. Bernard GR, Ely EW, Wright TJ, et al. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med. 2001;29:2051-2059.
8. Joyce DE, Gelbert L, Ciaccia A, et al. Gene expression profile of anti-thrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem. 2001;276:11199-11203.
9. Linscheid P, Schaffner A, Blau N, et al. Regulation of 6-pyruvoyltetrahydropterin synthase activity and messenger RNA abundance in human vascular endothelial cells. Circulation. 1998;98:1703-1706.
10. Franscini N, Blau N, Walter RB, et al. Critical role of interleukin-1 beta for transcriptional regulation of endothelial 6-pyruvoyltetrahydropterin synthase. Arterioscler Thromb Vasc Biol. 2003;23:50-53.
11. Overview of LightCycler quantification methods. Roche Applied Science. Technical Note No. LC 10/2000.
12. Absolute quantification with external standards. Roche Applied Science. Technical Note No. LC 11/2000.
13. Shen Z, Peedikayil J, Olson GK, et al. Multiple transcription factor profiling by enzyme-linked immunoassay. Biotechniques. 2002;32:1168:1170-1172.
14. Gurtius H-C, Blau N, Kuster T. Pterins. In: Hommes FS, ed. Techniques in Diagnostic Human Biochemical Genetics. New York, NY: Wiley-Liss; 1991:377-396.
15. Katusic ZS, Stelter A, Milstien S. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18:27-32.
16. Schoedon G, Schneemann M, Blau N, et al. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: new perspectives on endothelium-derived relaxing factor. Biochem Biophys Res Commun. 1993;196:1343-1348.
17. Rosenkranz-Weiss P, Sessa WC, Milstien S, et al. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin invest. 1994;93:2236-2243.
18. Yoshizumi M, Perrella MA, Burnett JC Jr, et al. Tumor necrosis factor down-regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209.
19. Mohamed F, Monge JC, Gordon A, et al. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol. 1995;15:52-57.
20. Lin PS, Ho KC, Sung SJ, et al. Effect of tumour necrosis factor, heat, and radiation on the viability and microfilament organization in cultured endothelial cells. Int J Hyperthermia. 1992;8:667-677.
21. Benotmane AM, Hoylaerts MF, Collen D, et al. Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium. Anal Biochem. 1997;250:181-185.
22. Munoz C, Castellanos MC, Alfranca A, et al. Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J Immunol. 1996;157:3587-3597.
23. Dixit VM, Marks RM, Sarma V, et al. The antimitogenic action of tumor necrosis factor is associated with increased AP-1/c-jun proto-oncogene transcription. J Biol Chem. 1989;264:16905-16909.
24. Wang N, Verna L, Hardy S, et al. Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol. 2001;21:1414-1420.
25. Ahmad M, Theofanidis P, Medford RM. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J Biol Chem. 1998;273:4616-4621.
26. Martin T, Cardarelli PM, Parry GC, et al. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol. 1997;27:1091-1097.
27. Chen F, Castranova V, Shi X, et al. New insights into the role of nuclear factor-kappa B, a ubiquitous transcription factor in the initiation of diseases. Clin Chem. 1999;45:7-17.
28. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:612-621.
29. Weiler H, Isermann BH. Thrombomodulin. J Thromb Haemost. 2003;1:1515-1524.
30. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408-416.
31. Riewald M, Petrovan RJ, Donner A, et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.
32. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
33. Mesters RM, Helterbrand J, Utterback BG, et al. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med. 2000;28:2209-2216.